
CNXC Stock Forecast & Price Target
CNXC Analyst Ratings
Bulls say
Concentrix Corporation shows a positive outlook due to anticipated improvements in gross margins driven by increased technology integration into its products and offshore human agent delivery. The company's total revenue demonstrated resilience with a 4% year-over-year increase and an upward revision in revenue guidance, projecting constant currency growth for the full year to be between 1.75-2.0%. Additionally, a strong sales pipeline across multiple industries and regions, bolstered by significant adoption of proprietary AI solutions, positions Concentrix for continued revenue and non-GAAP EPS growth in the upcoming years.
Bears say
Concentrix Corp experienced a decline in adjusted EBITDA margins year-over-year, falling from 16.3% to 14.5%, alongside a decrease in adjusted operating margins from 13.9% to 12.3% in fiscal Q3/25, indicating challenges in maintaining profitability. The company's revised guidance reflects a projected decrease in non-GAAP operating income and earnings per share, with estimates lowered from $1,300-1,320 million to $1,250-1,260 million and from $11.53-11.76 to $11.11-11.23, respectively. Additionally, a significant drop in commoditized revenue, now expected to normalize closer to 5%, combined with adjustments to onshore and offshore delivery, has affected financial performance and raised concerns about the company's growth trajectory.
This aggregate rating is based on analysts' research of Concentrix Corporation and is not a guaranteed prediction by Public.com or investment advice.
CNXC Analyst Forecast & Price Prediction
Start investing in CNXC
Order type
Buy in
Order amount
Est. shares
0 shares